← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.91 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.90 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89 Optimized Temporal Window for Metabolic Boosting Therapy Det (IFNG) — 0.89 TREM2-APOE Axis Dissociation for Selective DAM Activation (TREM2-APOE axis) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.88 APOE-Dependent Autophagy Restoration (MTOR) — 0.88 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.87 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.87 Complement Cascade Inhibition Synaptic Protection (%s) — 0.87 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.87 Optogenetic restoration of hippocampal gamma oscillations vi (PVALB) — 0.87 Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated (PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway) — 0.87 Glymphatic-Mediated Tau Clearance Dysfunction (MAPT) — 0.86 Closed-loop focused ultrasound targeting EC-II PV interneuro (PVALB) — 0.86 TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima (NAMPT) — 0.86 TREM2-Mediated Microglial Dysfunction Disrupts Perivascular (TREM2) — 0.86 Circadian Glymphatic Entrainment via Targeted Orexin Recepto (HCRTR1/HCRTR2) — 0.86 RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P (RBM45,GSK3B,TDP-43,TARDBP,hnRNP A1,HNRNPA1,phase separation,Liquid droplet) — 0.86
Add
|
× Astrocyte C3aR Signaling × CD8+ T-Cell Perforin Path
C3, C3aR, NFKB1, PPARGC1A · Alzheimer's disease, Parkinson's disease · mechanistic
Composite 0.749
Price $0.63
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate starts from the claim that modulating C3, C3aR, NFKB1, PPARGC1A within the disease context of Alzheimer's disease, Parkinson's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate starts from the claim that modulating C3, C3aR, NFKB1, PPARGC1A within the disease context of Alzheimer's disease, Parkin
GZMB, PRF1, HLA-E, NKG2D · Alzheimer's disease, Parkinson's disease · mechanistic
Composite 0.699
Price $0.63
Evidence For 0
Evidence Against 0
## Mechanistic Overview
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss starts from the claim that modulating GZMB, PRF1, HLA-E, NKG2D within the disease context of Alzheimer's disease, Parkinson's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss starts from the claim that modulating GZMB, PRF1, HLA-E, NKG2D within the disease context of Alzheimer's disease, Pa
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Adaptive Immunity Astrocyte Reactivity Alzheimer's disease Parkinson's disease
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 8/11
dimensions won
Astrocyte C3aR Signaling as Bifurcation
5/11
dimensions won
CD8+ T-Cell Perforin Pathway as Driver o
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Astrocyte C3aR Signaling as Bi CD8+ T-Cell Perforin Pathway a Mechanistic 0.700 0.700 Evidence 0.750 0.710 Novelty 0.500 0.500 Feasibility 0.500 0.500 Impact 0.500 0.500 Druggability 0.000 0.000 Safety 0.000 0.000 Competition 0.000 0.000 Data 0.250 0.000 Reproducible 0.710 0.680 KG Connect 0.500 0.500
Evidence Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate No evidence citations yet
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid L No evidence citations yet
Price History Overlay